MoneyWorks4Me

Novartis - Quaterly Results

29 Jul 2025 Evaluate
The sales slipped to Rs. 875.50 millions for the June 2025 quarter as against Rs. 922.90 millions during the year-ago period.A slim rise of 7.30% was recorded in the Net profit for the quarter ended June 2025 to Rs. 276.20  millions  From Rs. 257.40 millions.Operating profit surged to 378.50 millions from the corresponding previous quarter of 343.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 875.50 922.90 -5.14 875.50 922.90 -5.14 3562.70 3350.70 6.33
Other Income 106.10 104.10 1.92 106.10 104.10 1.92 419.60 616.80 -31.97
PBIDT 378.50 343.80 10.09 378.50 343.80 10.09 1333.80 1269.40 5.07
Interest 1.00 1.50 -33.33 1.00 1.50 -33.33 7.70 14.90 -48.32
PBDT 377.50 342.30 10.28 377.50 342.30 10.28 1326.10 1254.50 5.71
Depreciation 5.30 5.50 -3.64 5.30 5.50 -3.64 21.90 26.10 -16.09
PBT 372.20 336.80 10.51 372.20 336.80 10.51 1304.20 1228.40 6.17
TAX 96.00 79.40 20.91 96.00 79.40 20.91 295.20 376.50 -21.59
Deferred Tax 0.00 -1.90 0.00 0.00 -1.90 0.00 -4.40 0.20 -2300.00
PAT 276.20 257.40 7.30 276.20 257.40 7.30 1009.00 851.90 18.44
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 43.23 37.25 16.05 43.23 37.25 16.05 37.44 37.88 -1.18
Peers